Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 17, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V.
| -2.22K |
$5.14 | -$11,410.80 | -9.90% | 20.2K |
Jun 13
| |||||||
Dianthus Therapeutics, Inc. /de/
|
0
|
—
|
—
|
—
|
0
|
May 23
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
|
May 15
| |||||||
Dianthus Therapeutics, Inc. /de/
|
0
|
—
|
—
|
—
|
0
|
Sep 11
| |||||||
Dianthus Therapeutics, Inc. /de/
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
| 6.42K |
$18.99 | -$43,202.25 | +40.16% | 22.42K |
Jun 13 - Jun 16
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
|
May 17
| |||||||
Uniqure N.V.
| -384.00 |
$19.97 | -$7,668.48 | -2.34% | 16K |
Feb 27
| |||||||
Uniqure N.V.
|
0
|
$13.98 | -$103,320.00 |
—
| 16.38K |
Jan 18
|
Scheduled
| ||||||
Uniqure N.V.
|
0
|
$14.41 | -$159,384.00 |
—
| 16.38K |
Dec 13 - Dec 14
|
Scheduled
| ||||||
Uniqure N.V.
|
0
|
$25.38 | -$157,356.00 |
—
| 16.38K |
Nov 29
|
Scheduled
| ||||||
Uniqure N.V.
| 9.08K |
—
|
—
| +124.35% | 16.38K |
Jun 15
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Uniqure N.V.
| -596.00 |
$16.87 | -$10,054.52 | -7.55% | 7.3K |
Feb 28
| |||||||
Uniqure N.V.
| 1.53K |
—
|
—
| +24.10% | 7.9K |
Feb 24
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Rallybio Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
| -504.00 |
$37.60 | -$18,950.40 | -7.34% | 6.36K |
Mar 2
| |||||||
Uniqure N.V.
| 2.38K |
—
|
—
| +53.10% | 6.87K |
Feb 25
| |||||||
Uniqure N.V.
| 2.06K |
—
|
—
| +85.14% | 4.49K |
Feb 27
| |||||||
Uniqure N.V.
| -2.12K |
$60.95 | -$129,331.66 | -46.69% | 2.42K |
Feb 5
|
Scheduled
| ||||||
Uniqure N.V.
| -807.00 |
$62.19 | -$50,187.33 | -15.08% | 4.54K |
Jan 28
| |||||||
Uniqure N.V.
| -3.00K |
$72.18 | -$216,540.00 | -35.92% | 5.35K |
Jan 7
|
Scheduled
| ||||||
Uniqure N.V.
|
0
|
$37.94 | -$130,260.00 |
—
| 8.35K |
Dec 13
|
Scheduled
| ||||||
Uniqure N.V.
| -11.58K |
$64.96 | -$752,349.98 | -58.10% | 8.35K |
Dec 6 - Dec 9
|
Scheduled
| ||||||
Akcea Therapeutics, Inc.
| 678.15K |
$11.85 | -$8,486,713.73 |
∞
| 678.15K |
Sep 26
| |||||||
Akcea Therapeutics, Inc.
|
0
|
$19.30 | -$814,800.52 |
—
|
0
|
Apr 5 - Apr 8
|
Scheduled
| ||||||
Akcea Therapeutics, Inc.
|
0
|
$19.31 | -$471,714.89 |
—
|
0
|
Mar 6
|
Scheduled
| ||||||
Uniqure N.V.
| -1.21K |
$31.32 | -$37,897.20 | -5.72% | 19.93K |
Jan 28
| |||||||
Uniqure N.V.
| 3.23K |
—
|
—
| +18.03% | 21.14K |
Jan 25
| |||||||
Akcea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Uniqure N.V.
| -2.88K |
$18.53 | -$53,329.34 | -13.84% | 17.91K |
Jan 29
| |||||||
Uniqure N.V.
| 4.79K |
—
|
—
| +29.95% | 20.79K |
Jan 26
| |||||||
Akcea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Akcea Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
|
Jan 27
| |||||||
Uniqure N.V.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.